Literature DB >> 16929540

Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis.

Jolanta Malyszko1, Jacek S Malyszko, Krystyna Pawlak, Michal Mysliwiec.   

Abstract

Hepcidin is a small defensin-like peptide whose production by hepatocytes is modulated in response to anemia, hypoxia, or inflammation. Hepcidin could also act as an indicator of functional iron deficiency in these patients. Cross-sectional study was performed to assess hepcidin correlations with renal function, iron status, and hsCRP in patients with chronic renal failure on conservative treatment, on hemodialyses, and in kidney transplant recipients. Iron status, complete blood count, creatinine, albumin, lipids were assessed using standard laboratory methods. GFR was estimated using MDRD formula. Hepcidin and high sensitivity CRP were measured using commercially available kits. Ferritin and hepcidin were higher in hemodialyzed patients, kidney transplant recipients, and patients with chronic renal failure over controls. In patients with chronic renal failure, hepcidin correlated significantly with total protein, albumin, creatinine, and eGRF. In kidney transplant recipients, hepcidin correlated significantly in univariate analysis, with total protein, ferritin, time after transplantation, creatinine, eGRF and tended to correlate with cholesterol. In hemodialyzed patients hepcidin, correlated significantly with triglycerides, albumin, creatinine, urea, residual renal function, and hsCRP. In healthy volunteers, hepcidin was related to triglycerides and ferritin. Multiple regression analysis in hemodialyzed patients showed that hepcidin was independently related to creatinine, triglycerides, and residual renal function. Multiple regression analysis in kidney transplant recipients showed that hepcidin was independently related only to GFR and ferritin. Elevated hepcidin in all groups of patients studied may be due to low grade inflammation, frequently encountered in this population and mainly to impaired renal function. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16929540     DOI: 10.1002/ajh.20657

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  15 in total

1.  Urinary hepcidin-25 and risk of acute kidney injury following cardiopulmonary bypass.

Authors:  Julie Ho; Martina Reslerova; Brent Gali; Ang Gao; Jennifer Bestland; David N Rush; Peter W Nickerson; Claudio Rigatto
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 8.237

2.  Iron deficiency in children with early chronic kidney disease.

Authors:  Rossana Baracco; Sermin Saadeh; Rudolph Valentini; Gaurav Kapur; Amrish Jain; Tej K Mattoo
Journal:  Pediatr Nephrol       Date:  2011-06-28       Impact factor: 3.714

3.  Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort.

Authors:  Meredith A Atkinson; Ji Young Kim; Cindy N Roy; Bradley A Warady; Colin T White; Susan L Furth
Journal:  Pediatr Nephrol       Date:  2014-11-08       Impact factor: 3.714

Review 4.  Hepcidin in anemia of chronic kidney disease: review for the pediatric nephrologist.

Authors:  Meredith A Atkinson; Colin T White
Journal:  Pediatr Nephrol       Date:  2011-03-13       Impact factor: 3.714

5.  Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates.

Authors:  Jason S Troutt; Anthony M Butterfield; Robert J Konrad
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

6.  Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.

Authors:  Joshua Zaritsky; Brian Young; He-Jing Wang; Mark Westerman; Gordana Olbina; Elizabeta Nemeth; Tomas Ganz; Seth Rivera; Allen R Nissenson; Isidro B Salusky
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

7.  Hemodiafiltration improves plasma 25-hepcidin levels: a prospective, randomized, blinded, cross-over study comparing hemodialysis and hemodiafiltration.

Authors:  Bergur V Stefánsson; Mats Abramson; Ulf Nilsson; Börje Haraldsson
Journal:  Nephron Extra       Date:  2012-03-28

8.  Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease.

Authors:  Derek S Larson; Daniel W Coyne
Journal:  Kidney Res Clin Pract       Date:  2013-01-16

Review 9.  Laboratory use of hepcidin in renal transplant recipients.

Authors:  Lucija Šimetić; Lada Zibar
Journal:  Biochem Med (Zagreb)       Date:  2016       Impact factor: 2.313

10.  Association of hepcidin-25 with survival after kidney transplantation.

Authors:  Michele F Eisenga; Robin P F Dullaart; Stefan P Berger; John H Sloan; Aiko P J de Vries; Stephan J L Bakker; Carlo A J M Gaillard
Journal:  Eur J Clin Invest       Date:  2016-10-26       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.